Janney Montgomery Scott LLC Trims Position in BlackRock Health Sciences Trust (NYSE:BME)

Janney Montgomery Scott LLC lowered its holdings in BlackRock Health Sciences Trust (NYSE:BME) by 13.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 23,332 shares of the company’s stock after selling 3,529 shares during the period. Janney Montgomery Scott LLC’s holdings in BlackRock Health Sciences Trust were worth $978,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in BME. Calamos Advisors LLC increased its stake in shares of BlackRock Health Sciences Trust by 46.4% during the 2nd quarter. Calamos Advisors LLC now owns 7,884 shares of the company’s stock valued at $322,000 after acquiring an additional 2,500 shares during the last quarter. City of London Investment Management Co. Ltd. purchased a new stake in shares of BlackRock Health Sciences Trust during the 2nd quarter valued at $429,000. Logan Stone Capital LLC acquired a new stake in shares of BlackRock Health Sciences Trust during the 2nd quarter worth $600,000. Raymond James Trust N.A. raised its position in shares of BlackRock Health Sciences Trust by 8.1% in the 2nd quarter. Raymond James Trust N.A. now owns 22,036 shares of the company’s stock worth $900,000 after buying an additional 1,649 shares during the period. Finally, Consolidated Portfolio Review Corp boosted its holdings in BlackRock Health Sciences Trust by 133.8% in the second quarter. Consolidated Portfolio Review Corp now owns 39,721 shares of the company’s stock valued at $1,623,000 after acquiring an additional 22,729 shares during the last quarter.

BlackRock Health Sciences Trust Stock Performance

BlackRock Health Sciences Trust stock opened at $38.64 on Friday. BlackRock Health Sciences Trust has a 12 month low of $37.26 and a 12 month high of $42.86. The stock’s 50-day moving average is $41.31 and its 200-day moving average is $40.93.

BlackRock Health Sciences Trust Announces Dividend

The firm also recently disclosed a monthly dividend, which will be paid on Friday, November 29th. Stockholders of record on Friday, November 15th will be given a $0.213 dividend. This represents a $2.56 annualized dividend and a dividend yield of 6.61%. The ex-dividend date of this dividend is Friday, November 15th.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.